- The US is pushing to tie drug prices to foreign rates, amid global trends of price controls and health technology assessments.
- Europe is exploring drug pricing proposals with the Trump administration amid pressure over drug costs and tariffs.
The administration announced new tariffs on foreign drug manufacturers, impacting the global pharmaceutical industry.
1 report, 1 independent
Updated Jun 11
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
The administration announced new tariffs on foreign drug manufacturers, impacting the global pharmaceutical industry.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.- Pfizer and other companies are facing administration policy guidance regarding higher drug prices abroad in exchange for revenue sharing with HHS.Sub-event
Trump administration announces new tariffs on foreign drug manufacturers.1 source
Keep exploring
The entities involved
-
Donald Trump
American businessman and politician (born 1946), President of the United States (2017–2021; since 2025)
Related events
- Global tariffs from Donald Trump began on August 4, 2025, impacting international markets and financial news services like Bloomberg L.P.
- Trump administration imposed new import tariffs.
- The Trump administration is currently negotiating tariffs.
- Tariffs from U.S. President Trump are being implemented, creating economic challenges for British Columbia.
- Trump proposes tariffs on countries buying Russian oil and gas, while Fed policy affects global sentiment.